News

share

The US FDA has approved Sanofi and Regeneron Pharmaceuticals' Praluent (alirocumab) Injection as an adjunct to diet and...

share

GlaxoSmithKline (GSK) has received positive scientific opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for...

share

Eagle Pharmaceuticals has announced that the 505(b)(2) New Drug Application (NDA) for its novel ready-to-use bivalirudin product (RTU...

share

Akashi Therapeutics a clinical stage biopharmaceutical company developing treatments for Duchenne muscular dystrophy (DMD), announced positive interim clinical...

share

AstraZeneca has entered a two-year research collaboration with the University of Michigan to advance treatments for chronic kidney...

share

Italy-based Turin Advanced Neuromodulation Group director Dr Sergio Canavero has unveiled plans to carry out the first human...

share

Biopharmaceutical firm Lycera has entered an exclusive strategic collaboration with Celgene to advance the development of its proprietary...

share

Soligenix has entered a collaboration agreement with University of Hawaii at Manoa (UH Manoa) and Hawaii Biotech (HBI)...